Yen-Ting Lin

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

JCO precision oncology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine 13 (1) (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Yen-Ting Lin, Jin-Shing Chen, Wei-Yu Liao, Chao-Chi Ho, Chia-Lin Hsu, Ching-Yao Yang, Kuan-Yu Chen, Jih-Hsiang Lee, Zhong-Zhe Lin, Jin-Yuan Shih, James Chih-Hsin Yang, Chong-Jen Yu
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations. International journal of cancer 144 (11) (2019)
Chien-Hung Gow, Min-Shu Hsieh, Yen-Ting Lin, Yi-Nan Liu, Jin-Yuan Shih
Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas. Cancers 11 (6) (2019)